Advancing Medical Innovation Trailblazer Project Title: SH3BP2 inhibitors to target SH3BP2-mediated immune activation in nephrotic syndrome
By Kelly Hale, Marketing & Communications Specialist
May 08, 2024
PI: Tarak Srivastava, M.D., FASN, Children’s Mercy Hospital, Kansas City
Nephrotic syndrome is a kidney disease that is commonly associated with an activated immune system. For researchers, relapses of nephrotic syndrome are commonly triggered by viral infections and Tarak Srivastava, M.D., FASN, is studying why nephrotic syndrome is happening and if inhibiting the protein SH3BP2 could be an effective treatment.
“Right now, we’re treating nephrotic syndrome with steroids but the underlying defect in the immune system isn’t known,” said Srivastava, who is also collaborating with researchers at the University of Kansas - Lawrence. “There isn’t anything that targets this protein right now, so our research aims to identify a promising inhibitor to inhibit SH3BP2 protein.”
To accomplish this, Srivastava is using High Throughput Screening to screen 5000 compounds from a drug repurposing set using kidney cells that they have been modified to overproduce the SH3BP2 protein. They will select the top 10 – 15 compounds for further testing, including their safety and effectiveness at various points.
The ultimate goal is to identify a drug that can inhibit the SH3BP2 protein and potentially treat nephrotic syndrome.
Latest Articles
View All
Funded Projects · News
Funded Projects · News
TL1 Trainee · News
KL2 Scholar · News
News
TL1 Trainee · News
News
News
Funded Projects · News
TL1 Trainee · News
Events
TL1 Trainee · News
News
TL1 Trainee · News
KL2 Scholar · News
News
KL2 Scholar · News
Funded Projects · News
TL1 Trainee · News
TL1 Trainee · News
Services · News
News
Funded Projects · News
Funded Projects · News
Funded Projects · News
TL1 Trainee · News
KL2 Scholar · News
Funded Projects · News
News
News
News
News
News
News
News
News
News
News
News
News
News
Funded Projects · News
Funded Projects · News
KL2 Scholar · News
News
News
KL2 Scholar · News
KL2 Scholar
News
News
KL2 Scholar · News
News
News · In the Community · Funded Projects
Funded Projects · News
Funded Projects · News
Funded Projects · News
Funded Projects · News
News
Funded Projects · News
TL1 Trainee · News
Funded Projects · News
Events · News
Funded Projects · News
Funded Projects · News
TL1 Trainee · News
News · In the Community · Funded Projects
Funded Projects · News
KL2 Scholar · News
TL1 Trainee · News
News
News
KL2 Scholar · News
TL1 Trainee · News
News
News
Funded Projects · News
Events · News
KL2 Scholar · News
News
Funded Projects · News
News
Partner News · News
News · In the Community
0
Funded Projects · News
Funded Projects · News
News
Funded Projects · News
Funded Projects · News
News
Events · News
TL1 Trainee · News
News
Funded Projects · News
News
Partner News · News
TL1 Trainee · News
Events · News
News
News · KL2 Scholar
TL1 Trainee · News
Events · News
News
News
News
40
News
News
TL1 Trainee · News
News
Funded Projects · News
News · In the Community
Funded Projects · News
In the Community
News · In the Community · Partner News
KL2 Scholar · News
News · In the Community
Events · News · Services
Funded Projects · News
KL2 Scholar · Funded Projects · News
TL1 Trainee · Funded Projects · News
News
News
KL2 Scholar · Funded Projects
KL2 Scholar · Funded Projects
Events · News
News
KL2 Scholar · Funded Projects
News
Funded Projects
TL1 Trainee
News
Funded Projects